Skip to main content

Thymic plasmacytoma presenting as polyneuropathy and revealing multiple myeloma: a case report

Abstract

Background

Multiple myeloma (MM) is the most frequent malignant plasma cell disorder with proliferation of neoplastic plasma cells in the bone marrow or other tissue, most commonly in the upper aerodigestive tract. The invasion of the thymus is exceptional. Neurological complications are usual, but represent exceptionally the revealing symptom.

Case presentation

We report a case of polyneuropathy revealing a thymic plasmacytoma as a mediastinal invasion of MM in a 48-year-old woman. She was admitted after developing progressive ascending distal paresthesias and weakness in lower limbs. Examination showed symmetrical distal sensorimotor impairment with axillary and inguinal adenopathies. Electroneuromyography revealed a sensorimotor length-dependent neuropathy. Serum protein electrophoresis showed monoclonal protein peak in β-γ globulin region. Immunoelectrophoresis showed IgA lambda monoclonal gammapathy. Myelogram and bone marrow biopsy revealed plasmocytosis of 5%. Chest computed tomography showed a histologically confirmed thymic plasmacytoma associated with a lytic lesion of the 5th rib leading to the diagnosis of MM.

Conclusions

The association between a thymic plasmacytoma and peripheral neuropathy is rare and a workup for MM is necessary to guide therapeutic management.

Background

Monoclonal gammopathies are a heterogeneous group of disorders, caused by proliferation of monoclonal plasma cells or B-lymphocytes, ranging from the subclinical monoclonal gammopathy of undetermined significance, to malignant systemic disorders such as multiple myeloma (MM). Multiple myeloma is the most frequent malignant plasma cell disorder with proliferation of neoplastic plasma cells in the bone marrow (BM) or other tissues, most commonly in the upper aerodigestive tract and rarely in the anterior mediastinum [1]. Neurological complications are usual, but represent exceptionally the revealing symptom, particularly when it comes to polyneuropathy (PN) [2]. We report the case of PN revealing a thymic plasmacytoma as a mediastinal invasion of MM.

Case presentation

A 48-year-old woman, with no medical history, was admitted to our neurology department after developing gradually ascending distal paresthesia in the lower limbs over 2 months followed by lower limb weakness and gait disorders one month later with deterioration of the general condition. Family history was negative for inherited polyneuropathy. No history of infection was reported. She denied high-risk sexual behavior, any toxin exposure, bone pain or any sphincter impairment. Neurological examination showed sensory ataxia with a positive Romberg test and symmetrical distal motor impairment. Areflexia was noted in lower limbs with flexor plantar responses and hypoesthesia of gloves–socks type with no cranial nerve involvement. General exam revealed an axillary and inguinal adenopathies measuring 1 cm each. Electroneuromyography showed a severe sensorimotor length-dependent neuropathy with axonal mechanism in lower limbs. Cerebrospinal fluid (CSF) examination showed normal cellularity with an increased protein level (0.81 g/L). Brain magnetic resonance imaging (MRI) was normal. Spinal MRI showed osteolytic vertebral lesions. Complete blood count, urinalysis and other laboratory tests including calcium levels, thyroid hormones and cryoglobulin level were within normal limits. Viral serologic testing including human immunodeficiency virus, varicella-zoster virus and syphilis serology, tumor markers, antinuclear and antineuronal antibodies were negative. Monoclonal protein peak in β-γ globulin region measuring 5 g/l and elevated beta2 microglobulin (7 g/l) were noted on serum protein electrophoresis and IgA monoclonal gammapathy with lambda light chain restriction following immunoelectrophoresis. Myelogram and BM biopsy revealed plasmocytosis of 5%. VEGF serum level was normal. No amyloid deposits were found in the labial gland biopsy. Computed tomography scan showed a 35 × 30 × 50 mm mass in the right anterior and superior mediastinal region arising from the thymus (Fig. 1) with pleural effusion as well as a lytic lesion measuring 1.5 cm of the 5th rib with cortical bone rupture and soft tissue extension. The patient underwent percutaneous thymus biopsy and the lesion was histologically diagnosed as plasmacytoma. Tumor cells were positive for CD138 and multiple myeloma oncogene-1 (MUM-1) (Fig. 2). The diagnosis of multiple myeloma was made with the presence of a histologically confirmed plasmacytoma and one CRAB criteria (≥ 1 osteolytic lesion) [3]. The patient was referred to hematology department for further therapeutic management.

Fig. 1
figure 1

Chest computed tomography scan: mediastinal window. 36 × 36 × 50 mm mass in the right anterior and superior mediastinal region arising from the thymus (yellow arrows)

Fig. 2
figure 2

Microscopic examination of the thymus biopsy showed diffuse infiltrates of plasma cells with large and eccentric nuclei and abundant cytoplasm (H&E × 400) (A). Immunohistochemistry showed tumor cells with diffuse reactivity to CD138 (× 200) (B) and nuclear positivity to MUM1 (× 200) (C)

Plasmacytoma is a plasma cell neoplastic proliferation of the soft tissue, which frequently occurs in the BM, but can occasionally be located at extramedullary sites with the most common site being the upper aerodigestive tract [1]. The anterior mediastinum, particularly the thymus, is rarely involved and the literature consists mainly of reports of single cases [1]. Neurological complications represent exceptionally the revealing symptom, particularly when it comes to polyneuropathy. Our case presented initially a diagnostic dilemma; we initially thought of the diagnosis of extramedullary plasmacytoma (EMP) with tissue biopsy showing monoclonal plasma cell histology and bone marrow plasma cell infiltration not exceeding 5%. However, with the clinical presentation at onset, it is exceptional for a neuropathy [4] to be the revealing symptom of an EMP, especially when it comes to PN. Moreover, it is recommended with IgA monoclonal gammopathy to search for MM or POEMS (polyneuropathy, organomegaly, endocrinopathy, myeloma protein, and skin changes syndrome) and with an axonal neuropathy to search for amyloidosis or cryoglobulinemia [5]. Amyloid deposits were not found on labial biopsy and cryoglobulin level was normal. Our patient did not meet the criteria for POEMS syndrome with two mandatory major criteria, polyneuropathy and monoclonal gammopathy, and two minor criteria, pleural effusion and adenopathy. Even with the cytoalbuminologic dissociation in CSF examination, electroneuromyography did not fulfill the criteria for chronic inflammatory demyelinating polyneuropathy, which is the typical presentation during POEMS syndrome [6]. The diagnosis of thymic plasmacytoma with MM was reached after completing investigations with the presence of skeletal metastasis fulfilling the CRAB criteria [3], which has rarely been reported. Only 5% of patients with EMP have coexistent MM [7]. Another particularity is that IgA neuropathies are less common than IgM and IgG neuropathies (10 to 15%) [8, 9]. They are unlikely to be causally related to peripheral neuropathy [8] and could have a high tendency to evolution and malignancy [10]. Although some studies have shown deposition in the myelin sheath of crystalline inclusions in the peripheral nerve of a patient with IgA lambda monoclonal gammopathy of undetermined significance suggesting a possible causal link to the neuropathy [11], it was not observed or reported with MM yet. MM may cause neurological complications in the central or peripheral nervous system, dominated by spinal cord compression [6]. However, MM-related PN is rare [9], especially at onset. A recent study reported only 4 cases of MM out of 193 patients after investigating a clinic-biological presentation of polyneuropathy associated with monoclonal gammopathy and additional 4 patients who developed MM at a 3-year follow-up [2].

Its physiopathology is still not well understood. The main cause of MM-related PN is drug-related neurotoxicity [12], which is not the case of our patient. In general, the young age at onset pleads for the true causal association even though there is no specific test to confirm it [8]. It usually manifests as a length-dependent axonal sensorimotor neuropathy with involvement of all sensory modalities and mild distal weakness as in our patient [8, 13]. The presentation can be diverse and most often develop after the diagnosis of myeloma [9]. With our patient, PN was the revealing symptom. Our patient represents the third and youngest reported case to our knowledge to have an EMP in the thymus leading to the diagnosis of MM (Table 1). It is unique as an EMP was revealed by a polyneuropathy, which is extremely rare, but also the unusual site of the EMP in the thymus. Another interesting aspect is that the plasmacytoma raised the question of whether to consider it as a metastatic site of myeloma or the primary site of tumor growth resulting eventually in a MM.

Table 1 Clinical, radiological and biological data of patients with thymic plasmacytoma revealing a multiple myeloma

Conclusion

Thymic plasmacytoma is rarely associated with PN and a workup for MM invasion is mandatory even in the absence of BM plasmocytosis. The diagnosis rests largely on biological and biopsy results.

Availability of data and materials

The corresponding author takes full responsibility for the data, has full access to all of the data, and has the right to publish any and all data separate and apart from any sponsor.

Abbreviations

MM:

Multiple myeloma

BM:

Bone marrow

PN:

Polyneuropathy

CSF:

Cerebrospinal fluid

MRI:

Magnetic resonance imaging

MUM-1:

Multiple myeloma oncogene-1

EMP:

Extramedullary plasmacytoma

References

  1. Alexiou C, Kau RJ, Dietzfelbinger H, Kremer M, Spieß JC, Schratzenstaller B, et al. Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts [2] (multiple letters). Cancer. 2000; 88: 240–1. https://doi.org/10.1002/(SICI)1097-0142(20000101)88:1<240::AID-CNCR33>3.0.CO;2-W

  2. Eurelings M, Lokhorst HM, Kalmijn S, Wokke JHJ, Notermans NC. Malignant transformation in polyneuropathy associated with monoclonal gammopathy. Neurology. 2005;64(12):2079–84. https://doi.org/10.1212/01.WNL.0000176296.79088.9A.

    CAS  Article  PubMed  Google Scholar 

  3. Rajkumar SV. Multiple myeloma: 2018 update on diagnosis, risk-stratification, and management. Am J Hematol. 2018;93(8):1091–110. https://doi.org/10.1002/ajh.25117.

    CAS  Article  Google Scholar 

  4. Mankodi AK, Rao CV, Katrak SM. Solitary plasmacytoma presenting as peripheral neuropathy: a case report. Neurol India. 1999;47(3):234–7.

    CAS  PubMed  Google Scholar 

  5. Ahnach M, Marouan S, Rachid M, Madani A, Quessar A, Benchekroun S, et al. Extramedullary plasmacytoma relapsing at different sites: an unusual presentation. Pan Afr Med J. 2013. https://doi.org/10.11604/pamj.2013.14.34.1778.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Velasco R, Bruna J. Neurology · Neurosurgery · Medical Oncology · Radiotherapy · Paediatric Neuro-oncology · Neuropathology · Neuroradiology · Neuroimaging · Nursing · Patient Issues Neurologic Complications in Multiple Myeloma and Plasmacytoma. Eur Assoc NeuroOncol Mag. 2012;2(2):71–7.

    Google Scholar 

  7. Xu YH, Sun LG, Sun C, Bai O, Liang TT, Ma KW. Anterior mediastinum invasion by multiple myeloma: a case report. Oncol Lett. 2017;13(4):2637–41. https://doi.org/10.3892/ol.2017.5756.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Chaudhry HM, Mauermann ML, Rajkumar SV. Monoclonal gammopathy-associated peripheral neuropathy: diagnosis and management. Mayo Clinic Proc. 2017;92:838–50. https://doi.org/10.1016/j.mayocp.2017.02.003.

    Article  Google Scholar 

  9. Ramchandren S, Lewis RA. An update on monoclonal gammopathy and neuropathy. Curr Neurol Neurosci Rep. 2012;12:102–10. https://doi.org/10.1007/s11910-011-0237-4.

    CAS  Article  PubMed  Google Scholar 

  10. Filosto M, Cotelli M, Todeschini A, Broglio L, Vielmi V, Rinaldi F, et al. Clinical spectrum and evolution of monoclonal gammopathy-associated neuropathy. Neurologist. 2012;18(6):378–84. https://doi.org/10.1097/NRL.0b013e31826a99e9.

    Article  PubMed  Google Scholar 

  11. Vital A, Nedelec-Ciceri C, Vital C. Presence of crystalline inclusions in the peripheral nerve of a patient with IgA lambda monoclonal gammopathy of undetermined significance. Neuropathology. 2008;28(5):526–31. https://doi.org/10.1111/j.1440-1789.2008.00875.x.

    Article  PubMed  Google Scholar 

  12. Lozeron P, Adams D. Monoclonal gammopathy and neuropathy. Curr Opin Neurol. 2007;20:536–41. https://doi.org/10.1097/WCO.0b013e3282ef79e3.

    CAS  Article  PubMed  Google Scholar 

  13. Živkovi SA, Lacomis D, Lentzsch S. Paraproteinemic neuropathy. Leukemia Lymphoma. 2009;50:1422–33. https://doi.org/10.1080/10428190903111922.

    CAS  Article  Google Scholar 

  14. Masood A, Hudhud KH, Hegazi AZ, Syed G. Mediastinal plasmacytoma with multiple myeloma presenting as a diagnostic dilemma. Cases J. 2008;1(1):116. https://doi.org/10.1186/1757-1626-1-116.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Not applicable.

Machines used in the study

EMG & Evoked Potential Response Unit, Dantec Keypoint G3, Natus neurology, France; Computed Tomography: Siemens, Germany.

Funding

No funds were received to fulfill this work.

Author information

Authors and Affiliations

Authors

Contributions

SL, KSM and FK wrote the paper. SM and TS provided pathology data. NK and KBM contributed to the analysis of radiology data. NF, MD, ME and CM provided clinical revision of the paper. All authors approve of this final manuscript and accept responsibility for their respective roles. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Syrine Laroussi.

Ethics declarations

Ethics approval and consent to participate

All procedures performed in the study were in accordance with the ethical standards of the Faculty of Medicine of Sfax.

Consent for publication

Written informed consent was obtained from the participant for publication of this case and accompanying images.

Competing interests

The authors declare that they do not have any competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Laroussi, S., Moalla, K.S., Kallel, F. et al. Thymic plasmacytoma presenting as polyneuropathy and revealing multiple myeloma: a case report. Egypt J Neurol Psychiatry Neurosurg 58, 88 (2022). https://doi.org/10.1186/s41983-022-00522-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s41983-022-00522-5

Keywords

  • Polyneuropathy
  • Extramedullary plasmacytoma
  • Multiple myeloma
  • Thymus
  • Case report